MannKind Corporation

MNKD

$2.37

Name : MannKind Corporation

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $730,198,016.00

EPSttm : 0.02

MannKind Corporation

$2.37

3.95%

$0.09

MNKD — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

7.69

Margin Of Safety %

Put/Call OI Ratio

0.52

EPS Next Q Diff

0.07

EPS Last/This Y

0.08

EPS This/Next Y

0.13

Price

2.36

Target Price

7.5

Analyst Recom

1.44

Performance Q

-59.07

Upside

-70.5%

Beta

1.1

Ticker: MNKD

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	MNKD	3.04	0.29	1.30	55403
2026-03-03	MNKD	2.92	0.32	1.11	57022
2026-03-04	MNKD	2.94	0.31	0.19	57008
2026-03-05	MNKD	2.84	0.31	0.24	57823
2026-03-06	MNKD	2.6	0.28	0.03	58801
2026-03-09	MNKD	2.67	0.26	0.44	58438
2026-03-10	MNKD	2.61	0.27	0.29	59574
2026-03-11	MNKD	2.82	0.27	0.31	59736
2026-03-12	MNKD	2.82	0.27	0.36	60215
2026-03-13	MNKD	2.82	0.27	0.43	60215
2026-03-17	MNKD	2.73	0.30	0.17	61498
2026-03-18	MNKD	2.62	0.30	0.49	61912
2026-03-19	MNKD	2.51	0.30	0.22	62131
2026-03-20	MNKD	2.48	0.28	0.28	61401
2026-03-23	MNKD	2.43	0.36	0.14	49855
2026-03-24	MNKD	2.3	0.35	0.92	51670
2026-03-25	MNKD	2.28	0.35	0.04	52168
2026-03-26	MNKD	2.29	0.34	0.31	53090
2026-03-27	MNKD	2.28	0.33	1.77	53201
2026-03-30	MNKD	2.36	0.52	0.55	66701
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	MNKD	3.03	75.0	-	0.13
2026-03-03	MNKD	2.92	75.0	-	0.13
2026-03-04	MNKD	2.94	75.0	-	0.10
2026-03-05	MNKD	2.84	75.0	-	0.10
2026-03-06	MNKD	2.61	75.0	-	0.10
2026-03-09	MNKD	2.68	-58.3	-	0.10
2026-03-10	MNKD	2.61	-58.3	-	0.10
2026-03-11	MNKD	2.81	-58.3	-	0.10
2026-03-12	MNKD	2.81	-58.3	-	0.10
2026-03-13	MNKD	2.78	-58.3	-	0.10
2026-03-17	MNKD	2.73	-58.3	-	0.10
2026-03-18	MNKD	2.61	-58.3	-	0.10
2026-03-19	MNKD	2.51	-58.3	-	0.10
2026-03-20	MNKD	2.48	-58.3	-	0.10
2026-03-23	MNKD	2.43	-58.3	-	0.10
2026-03-24	MNKD	2.29	-58.3	-	0.10
2026-03-25	MNKD	2.28	-58.3	-	0.10
2026-03-26	MNKD	2.29	-58.3	-	0.10
2026-03-27	MNKD	2.27	-58.3	-	0.10
2026-03-30	MNKD	2.36	-58.3	-	0.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	MNKD	-3.56	2.68	8.88
2026-03-03	MNKD	-3.56	2.68	8.88
2026-03-04	MNKD	-3.56	2.68	8.88
2026-03-05	MNKD	-3.56	2.68	8.88
2026-03-06	MNKD	-3.56	2.68	8.88
2026-03-09	MNKD	-3.56	2.67	8.88
2026-03-10	MNKD	-3.56	2.67	8.88
2026-03-11	MNKD	-2.83	2.67	8.68
2026-03-12	MNKD	-2.83	2.67	8.68
2026-03-13	MNKD	-2.83	2.67	8.68
2026-03-17	MNKD	-2.83	2.71	8.68
2026-03-18	MNKD	-2.49	2.71	8.68
2026-03-19	MNKD	-2.49	2.71	8.68
2026-03-20	MNKD	-2.49	2.71	8.68
2026-03-23	MNKD	-2.49	2.99	8.68
2026-03-24	MNKD	-2.49	2.99	8.68
2026-03-25	MNKD	-2.49	2.99	7.69
2026-03-26	MNKD	-2.49	2.99	7.69
2026-03-27	MNKD	-2.49	2.99	7.69
2026-03-30	MNKD	-2.49	2.99	7.69
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.05

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

0.02

Insider Transactions

-2.49

Institutional Transactions

2.99

Beta

1.1

Average Sales Estimate Current Quarter

107

Average Sales Estimate Next Quarter

112

Fair Value

3.97

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

69.1

Max Drawdown 5-Year %

-69.4

Target Price

7.5

P/E

140.24

Forward P/E

20.83

PEG

0.29

P/S

2.09

P/B

P/Free Cash Flow

53.34

EPS

0.02

Average EPS Est. Cur. Y

0.1

EPS Next Y. (Est.)

0.23

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.68

Relative Volume

0.96

Return on Equity vs Sector %

-38.9

Return on Equity vs Industry %

-22.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

◆ MNKD Healthcare

$2.37

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

9/25

Volume

7/15

Valuation

18/20

TP/AR

2/10

Options

5/10

RSI

23.7

Range 1M

16.7%

Sup Dist

5.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

13/30

Estimates

4/20

Inst/Vol

5/15

Options

7/10

EPS Yr

-151.1%

EPS NY

1214.4%

52W%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +183.4% upside

Quality

8/30

Valuation

27/30

Growth

8/25

Stability

6/10

LT Trend

1/5

Upside

+183.4%

Quality

MoS

68%

MannKind Corporation

Sector: Healthcare

Industry: Biotechnology

Employees: 591

MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve glycemic control in adults with diabetes; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. Its products also include Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; FUROSCIX, a furosemide injection to treat fluid buildup in patients with chronic heart failure or chronic kidney disease. The company's pipeline of treatments for orphan lung diseases include MNKD-201, a dry-powder formulation of nintedanib for the treatment of idiopathic pulmonary fibrosis and MNKD-701. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.

MNKD

Latest News

—

Caricamento notizie per MNKD…

stock quote shares MNKD – MannKind Corporation Stock Price stock today

news today MNKD – MannKind Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch MNKD – MannKind Corporation yahoo finance google finance

stock history MNKD – MannKind Corporation invest stock market

stock prices MNKD premarket after hours

ticker MNKD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MNKD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y